Stocks · Health care · Pharmaceutical Preparations

ALUMIS INC.

ALMS Clue Score37
United States Fiscal year ends December CIK 0001847367 Results filed 13 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Mark Christopher Bradley
2 Nov 2026
Chief Development Officer
Sell
623
$6.52
$4.06K
Jorn Drappa
2 Nov 2026
Chief Medical Officer
Sell
593
$6.52
$3.87K
David M Goldstein
2 Nov 2026
Chief Scientific Officer
Sell
629
$6.52
$4.10K
Roy C. Hardiman
2 Nov 2026
Chief Business & Strategy Ofcr
Sell
652
$6.52
$4.25K
Sanam Pangali
2 Nov 2026
Chief Legal Officer
Sell
332
$6.52
$2.16K
John R. Schroer
2 Nov 2026
Chief Financial Officer
Sell
794
$6.52
$5.18K
Srinivas Akkaraju
8 Sep 2026
Director
Sell indirect
48,065
$10.55
$507.01K
Srinivas Akkaraju
8 Sep 2026
Director
Sell indirect
48,066
$10.55
$507.02K
Mark Christopher Bradley
3 Aug 2026
Chief Development Officer
Sell
2,572
$26.37
$67.82K
Jorn Drappa
3 Aug 2026
Chief Medical Officer
Sell
2,447
$26.37
$64.53K
David M Goldstein
3 Aug 2026
Chief Scientific Officer
Sell
2,596
$26.37
$68.46K
Roy C. Hardiman
3 Aug 2026
Chief Business & Strategy Ofcr
Sell
2,692
$26.37
$70.99K
Sanam Pangali
3 Aug 2026
Chief Legal Officer
Sell
1,364
$26.37
$35.97K
John R. Schroer
3 Aug 2026
Chief Financial Officer
Sell
3,282
$26.37
$86.55K

What was left out

Form 4 filings counted 93
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 14
Transactions with no price 0
Shares from compensation/vesting 69,669,054
History held since 1 Jul 2024